Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 245-950-9 | CAS number: 23949-66-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Toxicity (oral, rat, OECD 423): > 2000 mg/kg bw
Acute Toxicity (dermal, rat. similar to OECD 402): > 5000 mg/kg bw
Acute Toxicity (inhalation): data lacking
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 12th May 2014 to 27th May 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study conducetd according to international guidelines. No relevant deviations have been reported so that the study is considered reliable.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Species, strain, weight:
Rats, Wistar, 160 – 180g – weight suits to age of animals 6 – 7 weeks.
Females were nulliparous and non-pregnant.
Number and sex:
From the ordered 9 female and 3 male animals only 3 females and 3 males were employed, as the conditions of limit test at the dose 2000 mg/kg were satisfied.
Normally females are used in the test according to OECD TG 423 because mostly females are more sensitive gender, but if a new product is tested, there is still a possibility that this assumption will not be confirmed. For this reason one dose in males was used to verify sensitivity of sexes. In time of application animals reached body weight 195 – 215 g females, and 250 g males what falls into recommended age 8 – 12 weeks.
Source:
Accredited Breeding Velaz Prague (CZ)
Identification:
The animals were housed in groups by 3 in cages after application. They were marked on tail and numbering the cage with indicating sex, dose and date of application.
Housing:
Animals were housed in experimental animal house on the bedding (Lignocel S 3/4, Lufa – ITL GmbH Germany) in groups by 3 in cages in conformity with laboratory animals welfare legislation.
Diet:
A standard certified laboratory diet (supplier MP – OŠ – 06 extrudes, Snina, Slovak Republic) was served. The diet was routinely analysed by the manufacturer for nutritional components and environmental contaminants and by the independent laboratory.
Water:
Bottled tap drinking water, routinely (quarterly) analysed by accredited laboratory, was accessible ad libitum.
Environment:
Environmental controls for the animal room were set to maintain 22 ± 2oC, a relative humidity of 55 ± 10 %. The temperature and relative humidity of air were recorded and the records are included in primary documentation. A minimum of 10 air changes/hour, and artificial light regime12 h light/12 h dark were implemented.
Acclimation:
The animals were acclimated under the conditions of the test seven days before the beginning of the treatment. - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 1%
- Details on oral exposure:
- The test item was administered in a single dose by gavage using a stomach tube. Animals were fasted prior to dosing (food but not water was withheld over- night). Following the period of fasting, the animals were weighed and the test item administered. After the test item has been administered, food was withheld for a further 3-4 hours.
- Doses:
- The starting dose could be selected from the fixed dose levels of 5, 50, 300, and 2000 mg/kg. Available information indicated test item is likely to be nontoxic considering to acute toxicity.
A limit dose of 2000 mg/kg was used as starting dose. Group of 3 rats’ females were dosed.
As no test item-related mortality was produced additional group of 3 male rats were tested at the same dose no further dosing was necessary. - No. of animals per sex per dose:
- From the ordered 9 female and 3 male animals only 3 females and 3 males were employed, as the conditions of limit test at the dose 2000 mg/kg were satisfied.
- Control animals:
- no
- Details on study design:
- Animals were observed individually immediately, ½, 1, 2, and 4 hours after application and daily thereafter, for a total of 14 days.
Additional observations were not necessary. Clinical signs and conditions associated with pain, suffering, and impending death, are described in detail in a separate OECD Guidance
Observations included changes in skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous systems, and somatomotor activity and behaviour pattern. Attention was directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. No animal was found in a moribund condition.
Individual weights of animals were determined shortly before the test item was administered and weekly thereafter. Weight changes after first and second weeks after application were calculated and recorded.
All test animals were subjected to gross necropsy. Full, detailed gross necropsy included careful examination of external surface of the body, all orifices, and cranial, thoracic and abdominal cavities and their contents. All gross pathological changes were recorded for each animal. - Statistics:
- not applicable
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All 3/3 females and 3/3 males survived the limit dose 2000 mg/kg. No further dosing was necessary.
- Clinical signs:
- other: Neither in females nor in males visible symptoms were observed at the dosage of 2000 mg/kg during first 4 hours after application or in 14 day observation period.
- Gross pathology:
- All 3 males and 3 females survived observation period and were necropsied after euthanasia.
During necropsy no macroscopically changes were noticed - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The test item applied to 3 males and 3 females in limit dose 2000 mg/kg did not cause death either visible symptoms of toxicity during 14 day observation period. It can be concluded that the LD50 of the test item UV 312 is ˃ 2000 mg/kg after single oral administration to Wistar rats.
- Executive summary:
The objective of the study was to obtain information on the acute toxicity of test item when administered per orally in single dose to Wistar rats. The study was carried out in compliance with OECD TG 423 where the doses could be selected from the fixed dose levels of 5, 50, 300, and 2000 mg/kg. A limit dose of 2000 mg/kg was used as a starting dose. Groups of 3 females and 3 males were dosed. Since all 3/3 females and 3/3 males survived limit dose 2000 mg/kg no further dosing was necessary. The test item was applied to 3 males and 3 females. The limit dose 2000 mg/kg did not cause death, visible symptoms of toxicity during 14 day observation period or body weight loss. It can be concluded that LD50 of the test item is ˃ 2000 mg/kg, after single oral administration to Wistar rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The information is reliable and consistent with the database as a whole.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1975
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well documented study pre-dating OECD protocolls and GLP requirements. However, slight shortcomings regards documentation (e.g.number of animals, number of animals per dose ) justify a Klimisch 2 rating (reliable with restrictions).
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: CFY
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- The male rats weighted from 236 to 242 grams.
- Type of coverage:
- occlusive
- Vehicle:
- other: the test item pulver was prepared as a 40% suspension in aqueous gum tragacanth (0.5%)
- Details on dermal exposure:
- One day prior to treatment, hair was removed from the dorso-lumbar region of each rat with electric clippers exposing an area equivalent to 10% of the total body surface. No shaving or chemical depilation was used.
- Duration of exposure:
- The exposure period was of 24 hours. The skin of the animals was then decontaminated by washing with warm (40-50°C) dilute soap solution, rinsing in clean warm water and finally blotting dry with absorbent paper. The decontamonated animals were returned to their cages for a subsequent observation period of 14 days, during which a record was kept of all signs of toxicity.
- Doses:
- The test item was prepared as a 40% suspension in aqueous gum tragacanth (0.5%) and administrated at a dosage volume of 12.5 ml/Kg bodyweight by spreading evenly over the prepared skin.
- No. of animals per sex per dose:
- no data
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The treated areas of skin were examined daily for signs of dermal irritation and assessed according to the following scoring system:
erythema and eschar formation:
no erythema 0
slight erythema 1
well-defined erythema 2
moderate to severe erythema 3
severe erythema (beet redness) to slight eschar formation 4
(injuries in depth)
Oedema formation:
No oedema 0
slight oedema 1
well-defined oedema (area well defined by definite raising) 2
moderate oedema (raised approximately 1 mm) 3
severe oedema (raised more than 1 mm and extending 4
beyond the area of exposure). - Statistics:
- not applicable
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 other: g/Kg
- Based on:
- test mat.
- Mortality:
- There were no mortality or signs of toxicity.
- Clinical signs:
- other: Slight erythema was observed in one rat on the first three days following treatment.
- Gross pathology:
- Terminal autopsy findings were normal.
- Other findings:
- Control rats treated with the vehicle alone did not show any observable dermal reactions.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The acute median lethal percutaneous dose (LD50) to rats of Sanduvor pulver was found to be greater than 5.0 g/Kg bodyweight.
- Executive summary:
An acute dermal toxicity study was conducted in male rats. The test item was prepared as a 40% suspension in aqueous gum tragacanth (0.5%) and administrated at a dosage volume of 12.5 ml/Kg bodyweight by spreading evenly over the prepared skin. There were no deaths in the study, and no evidence of systemic toxicities or local irritation. Based on the results, the acute dermal median lethal dose (LD50) in rats was determined to be greater than 5.0 g/Kg bodyweight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The information is reliable and consistent with the database as a whole.
Additional information
The potential acute oral toxicity of the test material was evaluated in male and female rats in a study conducted according to the OECD Guideline for the Testing of Chemicals No. 423. It has been concluded that the test material has an LD50 of >2000mg/kg bodyweight (hameln rds a.s., section of Biological Studies, 2014).
The potential acute dermal toxicity of the test material was evaluated in male rats in a study conducted according to a standard similar to the OECD Guideline for the Testing of Chemicals No. 402. It has been concluded that the test material has an LD50 of >5000mg/kg bodyweight (Huntingdon Life Sciences, 2005).
The potential acute inhalation toxicity of the test material was evaluated in a study of Klimish 4 reliability, The study confirms that the substance has not inhalatory toxicity effects on rats.
Justification for selection of acute toxicity – oral endpoint
GLP study conducted according to international guidelines.
Justification for selection of acute toxicity – dermal endpoint
Well documented study pre-dating OECD protocolls and GLP requirements. However, slight shortcomings regards documentation (e.g.number of animals, number of animals per dose ) justify a Klimisch 2 rating (reliable with restrictions).
Justification for classification or non-classification
Acute Toxicity, oral: the substance has an acute oral LD50 of greater 2000 mg/kg bw. As a result, the substance does not meet the criteria for classification according to Regulation (EC) No 1272/2008, Annex I section 3.1.
Acute Toxicity, dermal: the substance has an acute dermal LD50 of greater 5000 mg/kg bw. As a result, the substance does not meet the criteria for classification according to Regulation (EC) No 1272/2008, Annex I section 3.1.
Acute Toxicity, inhalation: there is no information available concerning inhalation toxicity; data is lacking.
A Klimish 4 study confirms that the substance has not inhalatory toxicity effects on rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.